Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Muireann Ní Bhaoighill
Mechanistic Target of Rapamycin Inhibitors: Successes and Challenges as Cancer Therapeutics
Related publications
Histone Deacetylase Inhibitors as Cancer Therapeutics
Annals of Translational Medicine
Medicine
Letter: Mechanistic Target of Rapamycin Inhibitors-Do They Impact on Recurrence of Hepatocellular Carcinoma After Liver Transplantation?
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
Phosphatidylinositol 3-Kinase (PI3K) Inhibitors as Cancer Therapeutics
Journal of Hematology and Oncology
Cancer Research
Oncology
Hematology
Molecular Biology
The Mechanistic Target of Rapamycin: The Grand ConducTOR of Metabolism and Aging
Cell Metabolism
Cell Biology
Molecular Biology
Physiology
Letter: Mechanistic Target of Rapamycin Inhibitors-Do They Impact on Recurrence of Hepatocellular Carcinoma After Liver Transplantation? Authors' Reply
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
Protein Methyltransferase Inhibitors as Precision Cancer Therapeutics: A Decade of Discovery
Philosophical Transactions of the Royal Society B: Biological Sciences
Biochemistry
Agricultural
Genetics
Molecular Biology
Biological Sciences
Mammalian Target of Rapamycin and Caspase Inhibitors in Polycystic Kidney Disease
Clinical Journal of the American Society of Nephrology
Epidemiology
Nephrology
Critical Care
Transplantation
Intensive Care Medicine
The Role of Mechanistic Target of Rapamycin in Maintenance of Glomerular Epithelial Cells
Current Opinion in Nephrology and Hypertension
Internal Medicine
Nephrology
Emergence of TNIK Inhibitors in Cancer Therapeutics
Cancer Science
Cancer Research
Medicine
Oncology
